Brief: Poxel Receives Orphan Drug Designation From EC For PXL770, PXL065

Poxel SA

25/01/2023 06:32

Jan 25 (Reuters) - Poxel SA  POXEL.PA :
    * POXEL RECEIVES ORPHAN DRUG DESIGNATION FROM THE EUROPEAN
COMMISSION FOR PXL770 AND PXL065 FOR TREATMENT OF
ADRENOLEUKODYSTROPHY
    * POXEL RECEIVES ORPHAN DRUG DESIGNATION FROM THE EUROPEAN
COMMISSION FOR PXL770 AND PXL065 FOR TREATMENT OF
ADRENOLEUKODYSTROPHY

Source text for Eikon:  ID:nBwb8drDha 
Further company coverage:  POXEL.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))